title: Correction for Ingale et al., Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies.
authors.affiliation: Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
authors.forename: Jidnyasa
authors.initials: J
authors.lastname: Ingale
authors.affiliation: IAVI Neutralizing Antibody Center at TSRI, La Jolla, California, USA.
authors.forename: Karen
authors.initials: K
authors.lastname: Tran
authors.affiliation: Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California, USA.
authors.forename: Leopold
authors.initials: L
authors.lastname: Kong
authors.affiliation: Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Barna
authors.initials: B
authors.lastname: Dey
authors.affiliation: Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Krisha
authors.initials: K
authors.lastname: McKee
authors.affiliation: Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center at TSRI, La Jolla, California, USA.
authors.forename: William
authors.initials: W
authors.lastname: Schief
authors.affiliation: Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: Peter D
authors.initials: PD
authors.lastname: Kwong
authors.affiliation: Vaccine Research Center, NIAID, NIH, Bethesda, Maryland, USA.
authors.forename: John R
authors.initials: JR
authors.lastname: Mascola
authors.affiliation: Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA IAVI Neutralizing Antibody Center at TSRI, La Jolla, California, USA.
authors.forename: Richard T
authors.initials: RT
authors.lastname: Wyatt